Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. (Q53627473)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. |
scientific article |
Statements
Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. (English)
Gautam Shrikhande
Lalita Khaodhiar
Salvatore Scali
Christina Lima
Matthew Hubbard
Katherine Dudley
Om Ganda
Christiane Ferran
Aristidis Veves
1 April 2006
43
4
760-70; discussion 770-1